baber/WOPTO huggingface dataset:
Patent DE-20196865-T1 (DE)
Title: Verfahren zur verarbeitung eines reduzierungssignals eines 3d-schattens für bilder durch optische kohärenztomografie (oct)
Inventor: MEI SONG
IPC: G06T5/00
Filed: 2020-09-18
Abstract: Bildverarbeitungsverfahren, umfassend:Erlangen eines Energieprofils eines Bilds;Tiefpassfiltern des Energieprofils; undAnpassen des Bilds basierend auf dem gefilterten Energieprofil.
Patent DE-599376-T1 (DE)
Inventor: DOLLING ULF H
IPC: C07J75/00
Filed: 1993-11-12
Abstract: Disclosed is a new process for producing finasteride which involves reacting the magnesium halide salt of 17β-carboalkoxy-4-aza-5α-androst-1-en-3-one with t-butylamino magnesium halide, present in at least a 2:1 molar ratio to the ester, formed from t-butyl amine and an aliphatic/aryl magnesium halide at ambient temperature in an inert organic solvent under an inert atmosphere followed by heating and recovering the product finasteride.Also disclosed are two polymorphic crystalline Forms I and II of finasteride, and methods of their production.
Patent DE-652813-T1 (DE)
Inventor: BOIANJUIU GIDEON
IPC: B23B27/14
Filed: 1994-05-19
Abstract: PCT No. PCT/EP94/01626 Sec. 371 Date Mar. 16, 1995 Sec. 102(e) Date Mar. 16, 1995 PCT Filed May 19, 1994 PCT Pub. No. WO94/27772 PCT Pub. Date Dec. 8, 1994A drilling tool having an elongated body with a longitudinal axis and provided with at least one insert receiving pocket and an indexable cutting insert for use with the drilling tool for performing drilling action is disclosed. The insert of the drilling tool includes a rake face, relief flank faces, a base, a plurality of cutting edges, each defined between the rake face and adjacent relief flank face and included between two adjacent cutting corners. Each cutting edge has at least one set of component cutting edges, each set having two pairs of component cutting edges merging in a common point, each pair comprising a first and a second component cutting edge merging via a bridging section directed towards a central line constituting or parallel to a median line of the insert and passing through the common point. The component cutting edges are oriented with respect to the central line so that an outermost extremity of the second component cutting edge is closer to a center of the insert and to the central line than the outermost extremity of the first component cutting edge. This ensures that during the drilling action, a line parallel to the longitudinal axis and passing through the outermost extremity of the first component cutting edge intersects the second component cutting edge and the extremities overlap.
Patent ES-2321795-T1 (ES)
Title: Procedimientos para la deshidrohalogenacion selectiva de alcanos halogenados.
Inventor: WANG HAIYOU
IPC: C07C17/25
Filed: 2007-10-26
Abstract: Un procedimiento para la producción de una olefina fluorada que tiene de tres a seis átomos de carbono, comprendiendo el procedimiento exponer un alcano fluorado o clorado, que tiene de dos a seis átomos de carbono y un grado N de sustitución con halógeno que no sea flúor y un grado M de sustitución con flúor, a condiciones eficaces para convertir al menos alrededor de 20% en peso de dicho alcano en una o más olefinas que tienen un grado N-1 de sustitución con halógeno que no sea flúor y un grado M de sustitución con flúor.
Patent ES-2329867-T1 (ES)
Title: Procedimiento integrado para producir 2,3,3,3-tetrafluoropropano.
Inventor: MERKEL DANIEL C
IPC: C01B7/19
Filed: 2009-03-16
Abstract: Un método para preparar 2,3,3,3-tetrafluoroprop-1-eno, que comprende: a. proporcionar una composición de partida que comprende al menos un compuesto que tiene una estructura seleccionada de las Fórmulas I, II y III: CX2=CCl-CH2X (Fórmula I) CX3-CCl=CH2 (Fórmula II) CX 3-CHCl-CH 2X (Fórmula III) en las que X se selecciona independientemente de F, Cl, Br y I, con la condición de que al menos un X no sea flúor; b. poner en contacto dicha composición de partida con un primer agente fluorante para producir una primera composición intermedia que comprende 2-cloro-3,3,3-trifluoropropeno y un primer subproducto que contiene cloro; c. poner en contacto dicha primera composición intermedia con un segundo agente fluorante para producir una segunda composición intermedia que comprende 2-cloro-1,1,1,2-tetrafluoropropano; y d. deshidroclorar al menos una porción de dicho 2-cloro-1,1,1,2-tetrafluoropropano para producir un producto de reacción que comprende 2,3,3,3-tetrafluoroprop-1-eno y un segundo subproducto que contiene cloro.
Patent ES-2696851-T1 (ES)
Title: Colada resistente al calor
Inventor: FUKUDA YOSHIZUMI
IPC: F02B39/00
Filed: 2016-07-29
Abstract: Una colada resistente al calor, que comprende: una porción axial; y dendritas en una estructura de una región de la porción axial que se somete a procesamiento plástico, las dendritas con un ángulo promedio entre una dirección perpendicular a un eje central de la porción axial y ejes principales de las dendritas en un intervalo de 20 grados.
Patent ES-2083349-T1 (ES)
Title: Procedimiento para esmaltar un objeto, principalmente un articulo culinario.
Inventor: PIERA HENRI
IPC: B41M1/40
Filed: 1995-04-25
Abstract: EN EL PROCESO PARA REALIZAR UN ADORNO SOBRE UN OBJETO (1), SE APLICA SOBRE EL OBJETO AL MENOS UNA CAPA DE BARBOTINA DE FRITA DE ESMALTE, TRAS LO CUAL, SIN COCER DICHA CAPA, SE APLICA SOBRE ESTA ULTIMA UN ADORNO, EN ZONAS LOCALIZADAS, A BASE DE FRITA DE ESMALTE Y PIGMENTOS MINERALES. EL ADORNO SE REALIZA A PARTIR DE UNA PASTA (2) QUE COMPRENDE UN LIGANTE TERMOFUSIBLE O RETICULABLE POR RADIACION ULTRAVIOLETA, LA FRITA DE ESMALTE Y LOS PIGMENTOS, SIENDO ESTA PASTA (2) CALENTADA DURANTE SU APLICACION SOBRE LA CAPA DE BARBOTINA DE FRITA DE ESMALTE PARA HACER FUNDIR EL LIGANTE TERMOFUSIBLE, TRAS LO CUAL EL CONJUNTO SE CUECE PARA VITRIFICAR DICHA CAPA Y DICHO ADORNO.
Patent CY-1108694-T1 (CY)
Inventor: NGUYEN KIM
IPC: G07C9/00
Filed: 2009-01-15
Abstract: This invention pertains to methods and apparatus for accessing an electronic device by a data terminal, as well as a computer program product, an electronic device and a data terminal.
Patent CY-1111006-T1 (CY)
Title: Εκριμματαση ασθενειας alzheimer
Inventor: GURNEY MARK E
IPC: C12N5/06
Filed: 2009-02-18
Abstract: Η παρούσα εφεύρεση παρέχει το ένζυμο και τις ενζυματικές πορείες για διάσπαση της θέσης διάσπασης β εκριμματάσης της ΑΡΡ πρωτεΐνης και συναφή νουκλεϊνικά οξέα, πεπτίδια, φορείς, κύτταρα και προϊόντα απομόνωσης κυττάρου και δοκιμασίες.
Patent CY-1110278-T1 (CY)
Inventor: TARTARE-DECKERT SOPHIE
IPC: C12Q1/6883
Filed: 2010-02-18
Abstract: The invention concerns a method for screening agents capable of treating, by way of prevention or cure, obesity or one of the disorders associated with obesity by modulating the expression of the SPARC protein or of its activity. The invention also concerns a method for diagnosing obesity or one of the disorders associated with obesity by monitoring the expression rate of the SPARC protein or its activity. The invention further concerns a composition comprising an agent modulating the expression of the SPARC protein or its activity. The invention finally concerns the use of any agent modulating the expression of the SPARC protein or its activity for preparing a pharmaceutical composition for treating, by way of prevention or cure, obesity or one of the disorders associated with obesity.
Patent CY-1112251-T1 (CY)
Inventor: SALICE GIUSEPPE
IPC: B65D43/16
Filed: 2011-10-10
Abstract: A container for gifts or the like, of the type that is used for association with a food package, in particular, to be inserted in a chocolate egg, comprises two half-shells (2,4) which can be coupled mouth to mouth and with which are associated connection means (12,16) that can be mutually engaged in order to keep the two half-shells connected to one another; the connection means are preferably of the buckle type with a male element (12) integral with one half-shell and a female element (16) integral with the other half-shell, the male and female elements being mutually engageable. <IMAGE>
Patent CY-1112521-T1 (CY)
Title: Bordetella bronchiseptica εμβολιο
Inventor: DEARWESTER DON ALAN
IPC: A61K47/44
Filed: 2011-12-16
Abstract: Η εφεύρεση σχετίζεται με ανοσοενισχυτικά μίας λεκιθίνης, ενός ελαίου και ενός αμφιπαθητικού επιφανειοδραστικού παράγοντα τα οποία ανοσοενισχυτικά είναι ικανά να σχηματίζουν ένα εμβόλιο ευσταθούς γαλακτώματος ελαίου σε ύδωρ ούτως ώστε να ελαχιστοποιούνται οι τοπικές αντιδράσεις κατόπιν εμβολιασμού ζώου.
Patent CY-1113430-T1 (CY)
Title: Φορεις νικορανδιλης με ενισχυμενη σταθεροτητα
Inventor: POLI PIERO
IPC: A61K9/20
Filed: 2012-11-29
Abstract: Η εφεύρεση παρέχει έναν φορέα για νικορανδίλη, που κατά προτίμηση είναι στην μορφή μιας συσκευασίας πλακιδίου με κυψελίδες, που περιλαμβάνει έναν ή περισσότερους θύλακες δόσης πλακιδίου με κυψελίδες που κάθε ένας περιέχει τουλάχιστον ένα δισκίο νικορανδίλης και τουλάχιστον έναν θύλακα πλακιδίου με κυψελίδες που περιέχει μοριακό κόσκινο.
Patent CY-1114156-T1 (CY)
Title: Μεγαλης κλιμακας συνθεση επιλεκτικων ρυθμιστων υποδοχεων ανδρογονων
Inventor: STEINER MITCHELL S
IPC: C07C231/12
Filed: 2013-07-16
Abstract: Η παρούσα εφεύρεση αφορά συνθετική διεργασία για την παρασκευή νέας κατηγορίας παραγόντων στόχευσης υποδοχέων ανδρογόνων (ΑRΤΑ) οι οποίοι παρουσιάζουν ανδρογονική και αναβολική δραστικότητα μη στεροειδούς προσδέτη για τον υποδοχέα ανδρογόνου. Οι παράγοντες ορίζουν μια νέα υποκατηγορία ενώσεων οι οποίες είναι επιλεκτικοί ρυθμιστές υποδοχέων ανδρογόνων (SARΜ) χρήσιμοι για α) αντισύλληψη των ανδρών, β) θεραπευτική αγωγή μιας ποικιλίας σχετιζόμενων με ορμόνες καταστάσεων, για παράδειγμα καταστάσεων που σχετίζονται με Ανδρογονική Ανεπάρκεια στον Γηράσκοντα Άνδρα (ΑDΑΜ), όπως κόπωση, κατάθλιψη, μειωμένη λίμπιντο, σεξουαλική δυσλειτουργία, στυτική δυσλειτουργία, υπογοναδισμό, οστεοπόρωση, τριχόπτωση, αναιμία, παχυσαρκία, σαρκοπενία, οστεοπενία, οστεοπόρωση, και μεταβολές στη διάθεση και στη γνωστική λειτουργία, γ) θεραπευτική αγωγή καταστάσεων που σχετίζονται με την Ανδρογονική Ανεπάρκεια στις Γυναίκες (ΑDΙF), όπως σεξουαλική δυσλειτουργία, μειωμένη σεξουαλική λίμπιντο, υπογοναδισμό, σαρκοπενία, οστεοπενία, οστεοπόρωση, μεταβολές στη γνωστική λειτουργία και στη διάθεση, κατάθλιψη, αναιμία, τριχόπτωση, παχυσαρκία και ενδομητρίωση, δ) θεραπευτική αγωγή ή/και πρόληψη χρόνιας μυϊκής απώλειας, ε) μείωση της εμφάνισης, παύση ή πρόκληση ύφεσης προστατικού καρκίνου, στ) από του στόματος αντικατάσταση ανδρογόνων, ζ) πρόληψη ή/και θεραπευτική αγωγή καταστάσεων ξηροφθαλμίας, η) θεραπευτική αγωγή ή/και πρόληψη καλοήθους προστατικής υπερπλασίας (ΒΡΗ), θ) επαγωγή απόπτωσης σε ένα καρκινικό κύτταρο, ι) θεραπευτική αγωγή ή/και πρόληψη καρκίνων των θηλυκών σεξουαλικών οργάνων όπως μαστικού καρκίνου, μητριαίου καρκίνου και ωοθηκικού καρκίνου, ή/και άλλες
Patent CY-1119134-T1 (CY)
Title: Υποδοχεις της νεπριλυσινης
Inventor: FENSTER ERIK
IPC: C07D491/107
Filed: 2017-07-28
Abstract: Σε ένα σκέλος, η εφεύρεση σχετίζεται με ενώσεις με τον τύπο I: όπου: τα R1-R5 και Χ είναι όπως ορίζονται στην περιγραφή, ή με ένα φαρμακευτικώς αποδεκτό άλας των ενώσεων αυτών. Οι ενώσεις αυτές έχουν δραστηριότητα αναστολής της νεπριλυσίνης. Σε ένα άλλο σκέλος, η εφεύρεση σχετίζεται με φαρμακευτικές συνθέσεις οι οποίες περιέχουν τις ενώσεις αυτές, με μεθόδους για τη χρήση των ενώσεων αυτών και με διαδικασίες και με ενδιάμεσες ενώσεις για την παρασκευή των ενώσεων αυτών.
Patent CY-1119238-T1 (CY)
Title: Αλας ηλεκτρικου οξεος του 1-[2-(2-χλωρο-4-{[(r)-2-υδροξυ-2-(8-υδροξυ-2-οξο-1,2-διϋδροκινολιν-5-υλ)αιθυλαμινο]μεθυλ]}-5-μεθοξυφαινυκαρβαμοϋλ)αιθυλ]πιπεριδιν-4-υλ εστερα διφαινυλ-2-υλκαρβαμικου οξεος και χρηση αυτου για την θεραπεια πνευμονικων διαταραχων
Inventor: CHUDASAMA RESHMA
IPC: C07D401/12
Filed: 2017-08-22
Abstract: Άλας ηλεκτρικού οξέος του 1-[2-(2-χλωρο-4-{[(R)-2-υδροξυ-2-(8-υδροξυ-2-οξο-1,2-διϋδροκινολιν-5-υλ)αιθυλαμινο]μεθυλ}-5-μεθοξυφαινυλκαρβαμοϋλ)αιθυλ]πιπεριδιν-4-ύλ εστέρα διφαινυλ-2-υλκαρβαμικού οξέος ή διαλύτωμα αυτού για χρήση στην θεραπεία πνευμονικών διαταραχών.
Patent CY-1123495-T1 (CY)
Title: Σουλφοναμιδια ως αγωνιστες των gpr40 και gpr120
Inventor: DE PIZZOL MARIA
IPC: C07D231/42
Filed: 2020-10-08
Abstract: Η εφεύρεση αφορά ενώσεις που δρουν ως αγωνιστές του υποδοχέα 120 συζευγμένου με πρωτεΐνη G (GPR120) και/ή 40 (GPR40), και έχουν τον τύπο (Ι). Οι αναφερθείσες ενώσεις είναι χρήσιμες στην αντιμετώπιση νόσων ή διαταραχών που τροποποιούνται από τον GPR120 και/ή GPR40 όπως ο διαβήτης (ιδιαίτερα ο διαβήτης τύπου 2), η διαταραγμένη ανοχή στη γλυκόζη από του στόματος, η αντίσταση στην ινσουλίνη, η παχυσαρκία, οι διαταραχές που σχετίζονται με την παχυσαρκία, το μεταβολικό σύνδρομο, η δυσλιπιδαιμία, η αυξημένη LDL, τα αυξημένα τριγλυκερίδια, η φλεγμονή που προκαλείται από την παχυσαρκία, η οστεοπόρωση και οι καρδιαγγειακές διαταραχές που σχετίζονται με την παχυσαρκία.
Patent CY-1123735-T1 (CY)
Title: Φαρμακευτικη χρηση toy fam19a5 που εμπλεκεται στη ρυθμιση γλοιογενησης
Inventor: SEONG JAE YOUNG
IPC: A61K31/7088
Filed: 2020-11-25
Abstract: Η παρούσα εφεύρεση αφορά στη φαρμακευτική χρήση του FAM19A5 που εμπλέκεται στη ρύθμιση της γλοιογένεσης, και πιο συγκεκριμένα, στη χρήση του FAM19Α5 στην πρόληψη, διάγνωση ή θεραπεία βλαβών του κεντρικού νευρικού συστήματος, εκφυλιστικών εγκεφαλικών ασθενειών ή ασθενειών του κεντρικού νευρικού συστήματος, με το FAM19A5 εξαπλώνεται στα νευρικά βλαστοκύτταρα στα σπονδυλωτά και να ρυθμίζει τη γλοιογένεση.
Patent GR-920300047-T1 (GR)
Title: Radiofrequency wave treatment of a material using a selected sequence of modes
Inventor: ASMUSSEN JES
IPC: H05B6/74
Filed: 1992-08-26
Abstract: A radiofrequency wave apparatus including an applicator (112, 120) which provides multiple, sequenced processing modes for use in a method for heating a material is described. The modes in the applicator are selected to suit each stage of the processing of a material (B). The apparatus can include multiple circuits (11, 12 and 13) which couple the radiofrequency waves to the applicator using probes (111a, 121a and 122a) in the method. The result is the optimum processing of the material.
Patent GR-920300050-T1 (GR)
Title: Cell culture device
Inventor: BINOT PATRICK
IPC: C12M3/00
Filed: 1992-08-31
Abstract: PCT No. PCT/FR91/00246 Sec. 371 Date Jan. 14, 1992 Sec. 102(e) Date Jan. 14, 1992 PCT Filed Feb. 28, 1991 PCT Pub. No. WO91/15570 PCT Pub. Date Oct. 17, 1991.A cell culture device is disclosed where cells are confined in a liquid medium within a cell culture space. The cell culture space is delimited by at least three selectively permeable walls. One wall is formed by a sheet of tubes and is permeable to fresh nutrient medium, the second wall is formed of a layer of capillaries and is permeable to gaseous fluids, and the third wall acts as a micron sieve that allows the passage of spent nutrient medium, but retains the cells within the cell culture space. The cell culture device makes it possible to produce culture products, continuously and in bulk over a long period of time.
Patent HR-P20110222-T1 (HR)
Title: Device for mixing bone cement
Inventor: VOGT SEBASTIAN
IPC: B01F15/02
Filed: 2011-03-28
Abstract: The mixing device has a discharge tube (3) arranged in an opening (4) in a direction of a longitudinal axis in a displaceable manner. A mixing disk (5) is arranged at an end of the discharge tube, where the end is arranged inside a mixing cylinder (1). The mixing disk is provided with multiple mixing openings and a central outlet. The mixing disk is arranged between a closed front side i.e. screw cap (2), and a bottom of the mixing device. A handle (9) is fixed to the opposite end of the discharge tube in a detachable manner.
Patent HR-P20110640-T1 (HR)
Title: Cyclic amide derivatives, and their production and use as antithrombotic agents
Inventor: KUBO K
IPC: C07D403/04
Filed: 2011-09-07
Abstract: The present invention provides a cyclic amide derivative useful as a drug for treating thrombosis, which is represented by the formula (I):   
wherein R 1  represents an optionally substituted cyclic hydrocarbon group or an optionally substituted heterocyclic group, W represents a bond or an optionally substituted divalent chain hydrocarbon group, a represents 0, 1, or 2, X 1  represents an optionally substituted lower alkylene or an optionally substituted lower alkenylene, Y 1  represents - C(O)-, -S(O)- or -S(O) 2 -, A represents a piperazine ring which may be further substituted or a piperidine ring which may be further substituted, X 2  represents a bond or an optionally substituted lower alkylene, Y 2  represents -C(O)-, -S(O)-, -S(O) 2 - or -C(=NR 7 )-, X 3  represents an optionally substituted C 1-4  alkylene or an optionally substituted C 2-4  alkenylene, Z 3  represents -N(R 4 )-, -O- or a bond, Z 1  represents -C(R 2 )(R 2' )-, -N(R 2 )-, etc., and Z 2  represents - C(R 3 )(R 3' )-, -N(R 3 )-, etc., or a salt thereof.
Patent HR-P20120050-T1 (HR)
Title: Fluid exchange catheter system
Inventor: PANOTOPOULOS CHRISTOS
IPC: A61M1/00
Filed: 2012-01-16
Abstract: A method of delivering a solution including at least one drug is provided. The method includes providing a fluid exchange catheter system which includes an inner lumen, the proximal end of which is connected to an infusion mechanism configured to control infusion of a solution that includes at least one drug, and an outer lumen, the proximal end of which is connected to an aspiration mechanism configured to control aspiration of fluid from the body. The method also includes activating the infusion mechanism to infuse the solution into the body for a first infusion time period and at a first infusion pressure, disabling the infusion mechanism to stop infusion, and activating the aspiration mechanism to aspirate fluid for a first aspiration time period and at a first aspiration pressure. Also described is a method of unblocking a fluid exchange catheter.
Patent SI-1370453-T1 (SI)
Title: Magnet track braking device
Inventor: LEHMANN HENRY
IPC: B61H7/00
Filed: 2002-03-08
Abstract: The disclosure relates to a magnet track braking device comprising a magnetic base and/or support body and a pole shoe section containing a magnetic flow guiding area and a magnetic flow separating area. The disclosure is characterized in that the magnetic base and/or support body is made from materials having different magnetic characteristics, so that an increase in induction in the gap between the magnet track brake and the rail head is reduced when erosion occurs in the pole shoe section.
Patent SI-1587965-T1 (SI)
Title: Aluminium alloy with increased resistance and low quench sensitivity
Inventor: HOLLRIGL GUNTHER
IPC: C22C21/10
Filed: 2003-12-20
Abstract: The alloy comprises aluminum metal with production contaminants which individually constitute not more than 0.05 wt% and in total not more than 0.15 wt%. Other metals included in the alloy are 4.6-5.2 wt% Zn; 2.6-3.0 wt% Mg; 0.1-0.2 wt% Cu; 0.05-0.2 wt% Zr; not more than 0.05 wt% Mn; not more than 0.05 wt% Cr; not more than 0.15 wt% Fe; not more than 0.15 wt% Si; not more than 0.10 wt% Ti.  Preferred amounts of the metals are: 4.6 wt% Zn; 2.6-2.8 wt% Mg; 0.10-0.15 wt% Cu; 0.08-0.18 wt% Zr; not more than 0.03 wt% Mn; not more than 0.02 wt% Cr; not more than 0.12 wt% Fe; not more than 0.12 wt% Si; not more than 0.05 wt%Ti.  Independent claims are included for: a) a process for manufacturing plates up to 300 mm thick in the claimed alloy in which: A) the alloy is extruded to form bars not less than 300 mm thick; B) the bars are heated at not more than 20 degrees C/hr from 170-410 degrees C to 470-490 degrees C; C) the bars are homogenized for 10-14 hrs at 470-490 degrees C; D) bars are hot rolled to form plates; E) the plates are cooled to 400-410 degrees C to not more than 100 degrees C; F) plates are cooled to room temperature; G) plates are hardened: b) a similar process in which hot rolling to form plates is omitted and the final hardened bars are used as plates.
Patent SI-1541197-T1 (SI)
Title: Use of pipamperone and an SNDRI, SNRI or SSRI for the treatment of mood or anxiety disorders
Inventor: BUNTINX ERIK
IPC: A61K31/00
Filed: 2004-10-21
Abstract: The present invention relates to the use of compounds and compositions of compounds having D4 and 5-HT2A antagonistic, partial agonistic or inverse agonistic activity for the treatment of the underlying dysregulation of the emotional functionality of mental disorders (i.e. affect instability - hypersensitivity - hyperaesthesia - dissociative phenomena - etc). The invention also relates to methods comprising administering to a patient diagnosed as having a neuropsychiatric disorder a pharmaceutical composition containing (i) compounds having D4 antagonistic, partial agonistic or inverse agonistic activity and (ii) compounds having 5-HT2A antagonistic, partial agonistic or inverse agonistic, and (iii) any known medicinal compound and compositions of said compounds. The combined D4 and 5-HT2A antagonistic, partial agonistic or inverse agonistic effects may reside within the same chemical or biological compound or in two different chemical and/or biological compounds.
Patent SI-2695513-T1 (SI)
Title: Method and device for providing heat and carbon dioxide to vegetables and/or algae using power station flue gas
Inventor: CHEN YILONG
IPC: F28F1/00
Filed: 2012-03-31
Abstract: Disclosed are a method and a device for providing heat and carbon dioxide to vegetables and/or algae using power station flue gas. The method comprises the steps of: introducing the flue gas into a first-stage heat exchange station (5) to carry out a first heat exchange with air and provide hot air to a vegetable greenhouse (6) and/or an algae cultivation room (9); introducing a part of the flue gas which has experienced cooling in the first-stage heat exchange station into a second-stage heat exchange station (12) to carry out a second heat exchange with air and cool the flue gas temperature to an extent suitable for extracting carbon dioxide; extracting carbon dioxide from the flue gas and supplying the carbon dioxide into the vegetable greenhouse and/or the microalgae carbon-absorbing pool of the algae cultivation room. The device mainly consists of a flue gas delivery pipe (4) connected to a flue gas induced draught fan (3), the first stage heat exchange station (5), a flue gas returning pipe (1) connected to a chimney, the second stage heat exchange station (12), a CO2 pressure swing adsorption device (14) and a CO2 gas storage tank (16), etc. It reduces energy waste and environmental pollution due to direct emission by means of comprehensive utilization of the flue gas, at the same time solves the difficult problem that the yield of vegetables and/or algae is insufficient in winter.
Patent SI-2858987-T1 (SI)
Title: Phosphoramidic acid prodrugs of 5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)pyridine-3-sulfonamide
Inventor: WARRIER JAYAKUMAR S
IPC: C07F9/00
Filed: 2013-06-10
Abstract: A compound of structural formula (I), wherein R is H or -PO3H or a pharmaceutically acceptable salt form thereof. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
Patent TR-200201365-T1 (TR)
Title: Tabancaların fişek hazneleri için uzatılabilir kapak plakası
Inventor: BERETTA UGO GUSSALLI
IPC: F41A9/65
Filed: 2001-06-07
Abstract: Bulusa göre kapak plakasi (II), bir tabancanin (13) kabzasi içine sokulan bir fisek haznesi bölmesine (12) takilir. Kapak plakasi, kapak plakasiyla (11) ayni seviyede ve düzlemde olan bir geri çekilmis atil pozisyon ile, kabzanin en azindan ön tarafinda kavrama yüzey alaninda geçici bir büyüme saglamak için asagiya dogru uzatilmis bir pozisyon arasinda hareket eden bir uzatilabilir element (17) içerir.